Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior—Outcomes of a randomized trial-Reference-Cited by-同舟云学术

Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior—Outcomes of a randomized trial

Published:2013-12 Issue:2 Volume:133 Page:376-382
ISSN:0376-8716
Container-title:Drug and Alcohol Dependence
language:en
Short-container-title:Drug and Alcohol Dependence

Author:

Otiashvili David,Piralishvili Gvantsa,Sikharulidze Zura,Kamkamidze George,Poole Sabrina,Woody George E.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Toxicology

Reference53 articles.

1. Effectiveness of buprenorphine maintenance treatment as compared to a syringe exchange program among buprenorphine misusing opioid-dependent patients;Aalto;Nord. J. Psychiatry,2011

2. Controlled, randomized trial in maintenance treatment of intravenous buprenorphine dependence with naltrexone, methadone or buprenorphine: a novel study;Ahmadi;Eur. J. Clin. Invest.,2003

3. Treatment of intravenous buprenorphine dependence. A randomized open clinical trial;Ahmadi;Ger. J. Psychiatry,2003

4. Buprenorphine injection in Melbourne, Australia–an update;Aitken;Drug Alcohol Rev.,2008

5. Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users;Alho;Drug Alcohol Depend.,2007

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Considerations when prescribing opioid agonist therapies for people living with HIV;Expert Review of Clinical Pharmacology;2024-07-02

2. Sexually transmitted and blood‐borne infection risk reduction with methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder: Findings from a Canadian pragmatic randomized trial;HIV Medicine;2024-03-20

3. Estimated effectiveness and cost-effectiveness of opioid use disorder treatment under proposed U.S. regulatory relaxations: A model-based analysis;Drug and Alcohol Dependence;2024-03

4. Pregnancy- and parenting-related barriers to receiving medication for opioid use disorder: A multi-paneled qualitative study of women in treatment, women who terminated treatment, and the professionals who serve them;Women's Health;2024-01

5. Dynamic changes in methadone utilisation for opioid use disorder treatment: a retrospective observational study during the COVID-19 pandemic;BMJ Open;2023-11